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Abstract 
Purpose: To establish a rapid molecular method for the detection of aldehyde dehydrogenase 2 
(ALDH2), and determine whether the polymorphic ALDH2 gene is associated with drinking behavior in a 
Chinese population. 
Methods: The gene polymorphism of ALDH2 *2 was detected using pyrosequencing and TaqMan real-
time polymerase chain reaction (PCR) techniques. Genotyping of 176 volunteers were performed at The 
Third Hospital of Wuhan, Hubei, China. Genetic associations with alcohol use behavior was assessed.  
Results: Pyrosequencing and TaqMan real time PCR methods were successfully developed to identify 
ALDH2 *2 polymorphisms. The allele frequencies of ALDH2 *2 were 21.31 % in the Chinese population. 
While the genotype frequency of heterozygous ALDH2 *1/ *2 plus homozygous ALDH2 *2/ *2 was 46.67 
% in non-drinkers, it was 30.17 % in the alcoholics group (p = 0.030). The allele frequency of ALDH2 *2 
was 15.09 % in the alcoholics group and 28.33 % among non-drinkers (p = 0.011). There were 
substantial differences in allele frequencies of ALDH2 genotypes between this study’s Chinese sample 
and other ethnic groups in Asia; the frequency of ALDH2 *2 allele was significantly higher than that in 
European and Americans.  
Conclusion: The developed pyrosequencing and TaqMan real time PCR methods are rapid, accurate, 
high-throughput, convenient, and reliable for detecting ALDH2 polymorphisms. ALDH2 *2 gene protects 
against the development of alcoholism. The frequencies of ALDH2 in this Chinese population differ from 
those of other ethnic populations.  
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Alcohol in humans is oxidized to acetaldehyde, 
which in turn is oxidized to harmless acetate by 
aldehyde dehydrogenases [1]. Aldehyde 
dehydrogenases-2 (ALDH2) is the major enzyme 
for acetaldehyde elimination, and its 
polymorphisms determine blood acetaldehyde 
concentrations after alcohol consumption. The 
Glu487Lys polymorphism (ALDH2 *2) has been 
the most frequently studied. Such a 
polymorphism (G to A) generates an ALDH2 with 
much lower activity and causes much higher 
blood levels of acetaldehyde, which may 
contribute to susceptibility to carcinogenesis [2]. 
The Glu487Lys polymorphism has been reported 
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to be associated with many types of cancer, such 
as esophageal cancer [3]. For further analysis of 
these Single Nucleotide Polymorphisms (SNPs) 
and their relations to clinical outcomes, an 
accurate, rapid, and cost efficient method of SNP 
evaluation is needed, and it will have a positive 
roles to understand an individual's ALDH2 
genetic condition which will improve the quality of 
life. 
 
The conventional method for detection of the 
ALDH2 *2 mutation uses a PCR - RFLP 
(restriction fragment length polymorphism) 
followed by restriction enzyme digestion and 
agarose gel electrophoresis [4], which is both 
labor-intensive and time-consuming. 
Pyrosequencing was a DNA sequencing 
technique that was based on the detection of the 
pyrophosphate released during DNA synthesis 
[5], and was well suitable for large-scale 
screening for a short length DNA fragment. 
TaqMan genotyping assay with the real time 
PCR is a gold standard for the analysis of a 
limited number of SNPs in large sample 
collections, specifically when the site of an SNP 
is not detectable with a restriction enzyme. It 
allows the detection of both SNP alleles in a 
single reaction tube. 
 
In this study, our aim was to establish a rapid 
molecular method for the detection of ALDH2 by 
pyrosequencing and TaqMan real time PCR 
technologies to investigate the gene 
polymorphism of ALDH2 *2 in a Chinese 
population, and comprehensive comparison with 




Subjects and methods 
 
From December 2013 to June 2014, the 
participants, including hospital employers, 
general blue - collar laborers, and white-collar 
workers, who were excluded from the 
immunorelated diseases and other critical 
diseases, included 176 subjects (101 males and 
75 females, with an average age of 39.86 ± 9.45 
years) in this study. Each participant signed and 
completed questionnaires, including the data 
about his/her age, weight, height, education 
level, lifestyle, and self-reported alcohol intake 
status. All participants were requested to provide 
a blood sample. All study participants will sign an 
informed consent to agree to participate in the 
study in compliance with the Declaration of 
Helsinki [6]. This study was approved by the 
Ethics Committee of the Hospital of Wuhan 
(approval ref. no. 20131201). Three milliliters of 
fasting venous blood was collected from all 
subjects, and then the serum and blood clotting 
were separated. Genomic DNA was extracted 
from white blood cells using the TIANamp Blood 
DNA kit (Tiangen, beijing, China) following 
standard protocols.  
 
TaqMan real time PCR for ALDH*2 genotyping 
 
Primers and probes were synthesized by the ABI 
Company (USA). A 25 μL reaction mixture 
including 2 μL DNA, 23 μL TaqMan PCR master 
mix, primers, probes and deionized water (YZY 
Medical Science & Technology Co., Ltd, Wuhan, 
China) was placed in an MX3000P real - time 
PCR instrument (Stratagene Corp, USA). The 
reaction conditions were as follows: initial 
treatment with uracil - N - glycosylase at 95 oC 
for 10 min, denaturation at 95 oC for 10 min, 
followed by 40 cycles of denaturation at 95 oC for 
15 s, and annealing and extension at 60 oC for 
45 s. The results were analyzed by the MX3000P 
Real Time PCR System, using the MxPro QPCR 
4.10d Software (Agilent). 
 
Pyrosequencing for ALDH2 *2 genotyping 
 
DNA amplification: One of the known primers of 
ALDH2 *2 was used for amplification of DNA for 
PCR analysis was biotinylated, respectively. 
Primers for pyrosequencing of ALDH2 *2 was 
designed with PyroMark Assay Design Software 
2.0. In the PCR assay (PyroMark PCR Kit - 
Qiagen), we used a forward primer that was 
biotinylated at the 5′ - end of the ALDH2 *2. The 
assay was performed in a 25 μL reaction volume. 
The PCR conditions consisted of initial 
denaturation at 95 oC for 15 min, followed by 45 
cycles of denaturation at 94 oC for 30 s, 
annealing at 60 oC for 30 s, extension at 72 oC 
for 30 s, and a final extension step at 72 oC for 
10 min. The PCR products were separated on 2 
% agarose gels.  
 
Biotinylated PCR products were immobilized on 
streptavidin - coated Sepharose beads 
(Streptavidin Sepharose High Performance, GE 
Healthcare). All of the streptavidin - coated 
Sepharose beads (2 μL per sample) were mixed 
with binding buffer (40 μL per sample) in a tube. 
High - purity water was then added to a total 
volume of 80 μL per well, including the PCR 
product (20 μL). This immobilization mix was 
incubated for 10 min at 25 oC with continuous 
mixing (1400 rpm) on a shaking device, and the 
sequencing primer was then diluted to 0.3 μmol/L 
in annealing buffer. Next, 25 μL of the solution 
was transferred to each well of a PyroMark Q24 
Plate. 
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After immobilization, the liquid was removed by 
aspirating the beads with a Vacuum Prep Tool 
and the beads were treated for approximately 5 s 
with 75 % ethanol, 5 s with denaturation buffer, 
and 5 s with washing buffer. PyroMark Q24 Plate 
containing the samples was heated at 80 oC for 2 
min using a PyroMark Q24 Plate Holder and a 
heating block. The plate was then removed from 
the plate holder and the samples were allowed to 
cool to room temperature (15 - 25 oC) for at least 
5 min, and the reagents, including enzyme and 
substrate mixtures, and nucleotides were added 
to the cartridge (PyroMark Q24, Qiagen) [7]. The 
samples were analyzed using a PyroMark Q24 
system (Qiagen) according to standard protocols. 
The order of nucleotide dispensation was chosen 
based on suggestions provided by PyroMark 




Statistical analysis was performed using SPSS 
11.5 software. One way ANOVA and t-test was 
used to compare mean differences for 
continuous variables. Allele frequency was 
determined via direct counting. The distribution of 
genotypes in all participants was obtained using 
Chi square test, and statistical significance was 




Results of TaqMan PCR 
 
Two primers and one pair of fluorescence-
conjugated probes were used in each reaction. 
The probe of allele 1 (G), which matched with the 
wild type was labeled with FAM (color green); the 
probe of allele 2 (A), which matched with the 
mutant was labeled with VIC (color red). Only 
significantly increased green fluorescence 
indicated the homozygous allele 1 (GG), only 
significantly increased red fluorescence indicated 
the homozygous allele 2 (AA), and an increase in 
both colors of fluorescence signals indicated the 




We identified each SNP for ALDH2 *2 using a 
singlet pyrosequencing method. The assay was 
designed to generate a specific sequence for the 
SNP by setting a suitable nucleotide addition 
(Figure 1). The sequencing data obtained from 
the pyrosequencing method was validated by 
TaqMan PCR of the SNP for randomly selected 
samples, and the results showed 100 % 
concordance with the TaqMan PCR results, 
indicating 100 % specificity and sensitivity for the 
newly developed method. 
 
Genetic polymorphism of ALDH2 *2 
 
The frequency of the ALDH2 *2 allele was 21.31 
%, and that of the ALDH2 *1 / *1, *1 / *2 and *2 / 
*2 genotypes were 60.79, 35.80 and 3.41 %, 
respectively (Table 1). Table 1 show the 
genotype and allele frequencies of ALDH2 in 
each group. Whereas the genotype frequency of 
heterozygous ALDH2 *1/ *2 plus homozygous 
ALDH2 *2/ *2 was 46.67 % in non-drinkers, they 
were 30.17 % in the alcoholics group (p = 0.030). 
The allele frequencies of ALDH2*2 were 15.09 % 
in the alcoholic group and 28.33 % in 
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Figure 1: Pyrosequencing for ALDH2 *2 genotyping. The pyrograms for ALDH2 *2 in individuals presenting with 
the following genotypes: ALDH2 *1/ *1 (A), ALDH2 *1/ *2 (B), ALDH2 *2/ *2 (C). The results were detected by the 
method of reverse sequencing, thus, the detected CC genotype was the actual GG genotype. By the same 
inference, the detected CT / TT genotypes were the actual AG / AA genotype respectively 
 
When we compared the allele frequencies of 
ALDH2 *2 polymorphisms in this population with 
those in other ethnic groups, the ALDH2 *2 
polymorphism frequency were found to be similar 
to those reported for a Japanese population, but 
differed from those in other ethnic groups 
including Mexican Americans, Native Americans, 




Table 1: Genotype and allele frequencies of ALDH2 
 
Group Genotype Allele frequency AA（%） AG（%） GG（%） A（%） G（%） 
Sample (n=176) 
Alcoholic (n=116) 
















*P = 0.030, compared with non-drinkers (AA plus GG), **p=0.011, compared with non-drinkers; percentage values 
are in parenthesis 
 
Table 2: Comparisons of ALDH2 *2 allele frequencies with those in other ethnic groups 
 
ALDH2 *2 




























In Asia, the frequency of the ALDH2 *2 allele was significantly higher than in European and American populations 
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In this study, we developed a rapid and robust 
pyrosequencing and TaqMan PCR methods to 
detect ALDH2 SNP and applied this technique to 
identify the SNP in a Chinese population, and we 
compared both procedures and found the results 
were the same. To our knowledge, this is the first 
study to identify ALDH2 polymorphisms using 
pyrosequencing and TaqMan PCR methods 
simultaneously. Previously, ALDH2 SNPs were 
detected through PCR-RFLP [4]. The 
pyrosequencing method presented here is 
directly applicable to studies involving genetic 
determination of ALDH2 polymorphisms in a 
large sample population.  
 
A key advantage of pyrosequencing is that direct 
sequence data for each DNA are obtained which 
means that little interpretation is necessary 
compared with other methods, such as RFLP 
analysis, where incomplete digestion may 
complicate data analysis. Furthermore, the time 
and cost per sample for pyrosequencing are less 
than for RFLP analysis [16]. A method using real-
time PCR offers an advantage over RFLP in that 
it can be modified for high-throughput 
applications, but it does not provide direct 
sequencing of DNA and therefore still requires 
some data interpretation. Compared with 
pyrosequencing, the real - time PCR method has 
less experimental procedures, the result of the 
genotype could be read directly by the outcome 
of PCR. Thus, pyrosequencing and TaqMan 
PCR methods have different strengths, they all 
showed high accurate, high-throughput, 
sensitivity, convenience.   
 
ALDH2, located on chromosome 12q24.2, is the 
primary enzyme responsible for acetaldehyde 
metabolism in the liver, and thus, represents a 
logical candidate gene for alcohol dependence. A 
mutation in ALDH2 produces a largely inactive 
aldehyde dehydrogenase enzyme that leads to 
elevated acetaldehyde levels that produces an 
aversive flushing reaction when alcohol is 
consumed. This ALDH2 *2 allele is relatively 
frequent in Far East Asian populations and has 
been associated with lower rates of alcohol use 
and alcoholism in Japanese and Chinese 
samples [17].  
 
In the present study, the frequency of the ALDH2 
*2 allele was 22.31 %. We observed that there 
were substantial differences in allele frequencies 
of ALDH2 genotypes between our Chinese 
sample and other ethnic groups in Asian. The 
frequency of the ALDH2 *2 allele were 
significantly higher than European and America. 
The genotype frequency of heterozygous ALDH2 
*1/ *2 plus homozygous ALDH2 *2/ *2 was 46.67 
% in nondrinkers, they were 30.17 % in the 
alcoholics group (p = 0.030). The allele 
frequencies of ALDH2 *2 were 15.09 % in the 
alcoholic group and 28.33 % in nondrinkers (p = 
0.011), showing that ALDH2 *2 gene protected 
against the development of alcoholism, because 
of the unpleasant symptoms (facial flushing, 
tachycardia, nausea,) after drinking. 
 
Limitations of the study 
 
While the present study has provided much 
useful information on a rapid molecular method 
for the detection of ALDH2 and whether the 
polymorphic ALDH2 gene is associated with 
drinking behavior in a Chinese population, it has 
several limitations that must be acknowledged. In 
this study, the sample size of participants was 
small, the result of which may be bias, and hence 




The developed pyrosequencing and TaqMan 
PCR methods are rapid and reliable genotyping 
methods to detect ALDH2 polymorphisms. 
ALDH2 *2 gene protects against alcoholism. 
There are large differences in the polymorphism 
of ALDH2 between the Chinese population in this 
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